Bacterial surface structure

Bacterial surface structures encompass a variety of macromolecular assemblies specific to the outermost layers of bacteria, including the cell wall (composed mainly of peptidoglycan in Gram-positive species and a complex cell envelope in Gram-negative species), capsules, slime layers, outer membrane, lipopolysaccharides (Gram-negative only), teichoic acids (Gram-positive only), lipoteichoic acids, and surface appendages such as flagella, fimbriae, and pili[3][4]. These structures mediate adhesion to host tissues, biofilm formation, motility, immune evasion, and play major roles in pathogenesis, chronic infection persistence, and antimicrobial resistance[1][2][3]. Drugs target these components either by inhibiting vital biosynthetic enzymes (e.g., transpeptidases for peptidoglycan cross-linking targeted by β-lactams)[3], disrupting membrane barriers (e.g., polymyxins), or interfering with adhesion and biofilm matrix formation[1]. Importantly, this "target" is a collective reference to several molecules rather than a single defined therapeutic target. The plural, species-wide designation makes it non-canonical and too broad for direct drug development reference.

Other names

cell envelopecapsulecell wallouter membranefimbriaepiliflagellaextracellular polymeric substance (EPS) matrix

Inhibit cell wall synthesis or assembly (e.g., β-lactams, glycopeptides)[3][4]; Increase membrane permeability/disruption (polymyxins, surfactants)[2]; Block bacterial adhesion (anti-fimbriae agents); Degrade EPS matrix (biofilm disruptors)[1]; Hydrolyze peptidoglycan (lysozyme)[2]